Hypoxic niches help maintain mesenchymal stromal cell properties, and their amplification under hypoxia sustains their immature state. However, how MSCs maintain their genomic integrity in this context remains elusive, since hypoxia may prevent proper DNA repair by downregulating expression of BRCA1 and RAD51. Here, we find that the ING1b tumor suppressor accumulates in adipose-derived stromal cells (ADSCs) upon genotoxic stress, owing to SUMOylation on K193 that is mediated by the E3 small ubiquitin-like modifier (SUMO) ligase protein inhibitor of activated STAT protein γ (PIAS4). We demonstrate that ING1b finely regulates the hypoxic response by triggering HIF1α proteasomal degradation. On the contrary, when mutated on its SUMOylation site, ING1b failed to efficiently decrease HIF1α levels. Consistently, we observed that the adipocyte differentiation, generally described to be downregulated by hypoxia, was highly dependent on ING1b expression, during the early days of this process. Accordingly, contrary to what was observed with HIF1α, the absence of ING1b impeded the adipogenic induction under hypoxic conditions. These data indicate that ING1b contributes to adipogenic induction in adipose-derived stromal cells, and thus hinders the phenotype maintenance of ADSCs. Cell Death and Disease (2015) 6, e1612; doi:10.1038/cddis.2014.577; published online 22 January 2015
Human mesenchymal stem/stromal cells (MSCs) are able to self-renew and differentiate into various cell types. Recently, MSCs have been developed as tools for tissue engineering and cell-based therapies 1 in particular owing to their trophic and immunosuppressive activities. 2 Conventionally, the bone marrow MSCs (BM-MSCs) and the adipose-derived stem/ stromal cells (ADSCs) have constituted the main sources of MSCs for clinical use. These cells are expanded in vitro prior to their application; however, this long-term culture may allow the emergence of senescence and phenotypic alterations, rendering MSCs unsuitable for clinical purposes. 3 To overcome these issues, MSC culture in conditions mimicking hypoxic niches has been tested. 4 Low O 2 tensions promote MSC growth, survival and maintain their selfrenewing multipotent state. 5 However, how hypoxia (1% O 2 ) affects MSC behavior is unclear. Responses to hypoxia are mainly mediated by hypoxia inducible factors (HIFs). HIF1, 2 and 3α subunits, are constitutively degraded in normoxia and stabilized in hypoxia. Consequently, when stabilized they can dimerize with HIF1β, and then translocate into the nucleus to modulate the expression of selected genes. HIF1α is highly expressed in MSCs, controls their metabolic fate and maintains them in an undifferentiated state. 6 HIF1α has also been shown to delay the occurrence of senescence in MSCs, by repressing E2A and p21 expression. 7 The inhibitors of growth (ING) family genes act as readers of the epigenetic histone code. Among them, ING1 has been described as a type II tumor suppressor, regulating cell growth, DNA repair, apoptosis, chromatin remodeling and senescence. 8 To some extent, ING1 and HIF might have opposite effects, (e.g. on tumor progression). Indeed, HIF1α, unlike ING1 that inhibits angiogenesis, promotes angiogenesis. 9 Furthermore, p53, a well-known ING1b interactor, and HIF1α have been shown in several studies to have antagonistic effects. Following DNA damage, p53 induces apoptosis and inhibits survival of cells by reducing activity and levels of HIF1α. 10, 11 So far, ING4 has been shown as the only ING protein to regulate the hypoxic response. Indeed, by interacting with HIF prolyl hydroxylase 2 (HPH-2), ING4 has been described to repress some HIF1α activities under hypoxic conditions. 12 Here, we show that ING1b accumulates in ADSCs following DNA damage in hypoxia. According to the opposing roles of ING1b and HIF1α, we hypothesized that ING1b could interfere with HIF1α and participate in the conservation of the genomic integrity of MSCs. Mechanistically, we found that ING1b interacted with HIF1α and promoted its proteasomal degradation in hypoxia. SUMOylation of ING1b played a role since the unSUMOylated form of ING1b was unable to trigger HIF1α degradation. The E3 small ubiquitin-like modifier (SUMO) ligase protein inhibitor of activated STAT protein γ (PIAS4) Figure 1) . Over 98% of cells were positive for CD90 and CD73 and o2% were positive for CD31 and CD45 13 ( Figure 1a ). To investigate the associated effects of variable O 2 tensions and genotoxic stress on ADSCs, we placed them either under 21% O 2 or under 1% O 2 , in the presence of doxorubicin ( Figure 1b) . As expected, HIF1α accumulated in hypoxic ADSCs but its expression decreased after the induction of DNA damage, while we observed an increase of ING1b. Following ING1 silencing, ADSCs displayed greater HIF1α protein levels in hypoxia, arguing for a specific relationship between HIF1α and ING1b ( Figure 2a) . Interestingly, ING1b knockdown led to HIF1α increase in normoxia as well (Figure 2b ). These effects did not appear to be dependent on ING4, since ING1 silencing had no noticeable effect on ING4 expression (Supplementary Figure 2) . The ING1b depletion did not affect HIF1α mRNA levels 48 h after siRNA transfection, suggesting that HIF1α regulation by ING1b may occur later at the mRNA level or rather at the protein level (Figure 2d ). This inverse relationship between ING1b and HIF1α was confirmed using transient overexpression of ING1b in ADSCs under hypoxic conditions, leading to a decrease of HIF1α (Figure 2c ). Together, these findings suggest that under hypoxic conditions, in response to a genotoxic stress, ING1b may trigger HIF1α degradation in ADSCs.
SUMOylation of ING1b triggers HIF1α degradation. We hypothesized that the ING1b effect on HIF1α may be associated with post-translational modifications. Indeed, the phosphorylation of ING1b is needed for its activity and stabilization.
14 Recently, ING1 was seen to be SUMOylated on K193, 15 and we demonstrated that ING1b may be mono or diSUMOylated in ADSCs as well (Supplementary Figure 3) . On the other hand, data on HIF1α SUMOylation are scarce, and the consequences of this modification remain unclear.
16,17 Accordingly, we thought that ING1b SUMOylation could be required for its HIF1α pro-degrading effects. A SUMOylation site prediction tool (SUMOplot Analysis Program http://www.abgent.com/sumoplot) identified the AKAE motif (192) (193) (194) (195) , located at the junction of the last nucleolar targeting sequence of the NLS domain and the REASP amino acid motif. As a consequence, a SUMOylation defective mutant was generated and named ING1b E195A (Figure 3a) . In U2OS cells, ING1b expression is higher than in ADSCs (Supplementary Figure 4) . As observed in ADSCs, HIF1α protein levels under hypoxic conditions increased in untransfected U2OS cells ( Figure 3b ) and a knockdown for ING1b led to an increase of HIF1α as well (Figure 3c (Figure 3f ). Assuming this lack of detectable protein interactions between ING1b WT and HIF1α might be due to a rapid degradation by the proteasome (Figure 3e ), HIF1α immunoprecipitation was performed in the presence of the MG132 proteasome inhibitor (Figure 3g ). By impeding proteasomal activity, the interaction between the ING1b WT and HIF1α proteins was detected.
The immunoprecipitation experiments suggested that ING1b E195A, unlike ING1b WT, might maintain interactions with HIF1α. This indicates that as long as ING1b is not The PIAS4-dependent stabilization of ING1b promotes PIAS4 decrease in return. Since we have recently described that the E3 conjugating enzyme PIAS4 participated in the ING1b SUMOylation, 15 we hypothesized that PIAS4 could be involved in the shift from a conservation to a degradation of HIF1α by regulating ING1b. We therefore investigated the role of PIAS4, a SUMO E3 ligase characterized to enhance ING1 SUMOylation and its activity, 15 but also described to regulate HIF1α. 16, 18 In Figures 4a and b , we showed that under hypoxic conditions, the induction of a genotoxic stress increased ING1b levels and led to a decrease of PIAS4 ( Figure 4a, lane 2) . Interestingly, a PIAS4 knockdown reduced ING1b protein levels in hypoxia after doxorubicin treatment, suggesting that ING1b accumulation in ADSCs relied on PIAS4 (Figure 4a, lane 4) . 19 By contrast, we observed that ADSCs submitted to an ING1b knockdown displayed increased PIAS4 levels in control cases and it was also the case following doxorubicin treatment but to a lesser extent (Figure 4b ). Then, we aimed to determine whether the PIAS4 decrease, related to the genotoxic stress in hypoxia, could be dependent on ING1b. Thus, we managed to block the protein translation with cycloheximide and we evaluated if the doxorubicin treatment could modulate PIAS4 protein levels ( Figure 4c ). By inhibiting the protein translation, we noticed a PIAS4 protein decrease following the doxorubicin treatment, but also that PIAS4 protein levels were less impaired when ING1b was knocked down. This suggested that doxorubicin reduced PIAS4 at a protein level through ING1b activities and that increasing levels of ING1b might oppose to PIAS4 (Figure 4c ). In a same manner, U2OS cells expressing ING1b WT, tended to feature lower amounts of PIAS4 compared with the ING1b E195A expressing cells in hypoxia ( Figure 4d ). Altogether, these data suggest that the increase of ING1b protein levels that occurs after this DNA damage may be attributable to a prior PIAS4-dependent SUMOylation. This then appears to allow the activated form of ING1b to contribute to the reduction of PIAS4 protein levels.
PIAS4 silencing leads to reduced HIF1α protein levels. SUMOylation has been shown to be a post-translational modification altering the stability or activity of several factors in the hypoxic pathway, including HIF1α. SUMOylation has been described to either stabilize or enhance HIF1α signaling, 20 its transcriptional activity 16, 18, 21 or to participate in the proteasomal degradation of HIF1α in hypoxia. 17, 22 To clarify the role of PIAS4, ADSCs and U2OS cells were knocked down for PIAS4 and treated with doxorubicin during hypoxia. Thereby, we observed in ADSCs that ING1b accumulation that is required for triggering HIF1α degradation, seems to be PIAS4 dependent following doxorubicin (Figure 4a, lane 3) . Interestingly, the doxorubicin deleterious effects on HIF1α were reduced in a substantial way when PIAS4 was silenced compared with its control (Figure 4a, lanes 2 and 4) . In hypoxia, a PIAS4 knockdown in U2OS cells expressing ING1b WT and ING1b E195A demonstrated that PIAS4 was required for the stability of HIF1α (Figure 4e, lanes 1 and 2) . Of note, in cells expressing ING1b WT, depletion of PIAS4 had no effect on HIF1α levels, hinting again that HIF1α depends on ING1b for its degradation and PIAS4 for its stabilization (Figure 4e,  lanes 3 and 4) .
ING1b and HIF1α modulate ADSCs fate. HIF1α has been described to reduce mesenchymal stromal cell commitment to adipocyte differentiation. 23 Therefore, we hypothesized that the lack of ING1b in hypoxic context could increase HIF1α levels, and subsequently impair differentiation processes. To verify this hypothesis, we knocked down ING1b expression and induced adipocyte differentiation. We observed that ADSCs depleted for ING1b could not express as much peroxisome proliferator-activated receptor γ2 (PPARγ2), lipoprotein lipase (LPL) or fatty acid binding protein 4 (FABP4), as their respective controls, after 7 days of adipogenic induction (Figure 5a ). Conversely, HIF1α-depleted cells expressed higher rates of these three adipocyte markers. This argues that ING1b takes part in adipocyte markers expressions while HIF1α prevents them. When these experiments lasted up to 14 days, we observed that adipogenesis still occurred after day 7, as judging by increasing rates of late adipocyte markers, that is, FABP4 and LPL. However, no significant difference was observed for adipocyte markers expression between control and ING1b-depleted cells (Figure 5d ). Adipogenic induction experiments were performed under normoxic conditions, a context more prone to adipocyte differentiation until day 7. We observed that this differentiation process was more efficient in normoxia and, by contrast to hypoxic conditions, ING1 silencing did not impair the adipocyte differentiation (Figure 5b,Supplementary  Figure 6 ). These findings suggest that during early adipogenic differentiation, hypoxia mediated a HIF1α-dependent decrease of adipocyte commitment, and conversely ING1b specifically favors expressions of adipocyte markers. Interestingly, the concomitant silencing of ING1b and HIF1α led to normal expression of adipocyte markers (Figure 5a ). This suggests that ING1b and HIF1α may have opposite effects on the early steps of adipogenic induction. Besides, after these 7 days of adipogenic induction, we observed that the expression of delta-like homolog 1/preadipocyte factor-1 (DLK1/PREF-1) expression decreased in all the tested cases, suggesting a loss in the mesenchymal character of ADSCs (Supplementary Figure 5) and an efficient induction of adipogenesis. 24 
Discussion
Long-term cultures expose MSCs to replicative stress or DNA damage, which may result in a loss of their multipotency and immunomodulatory properties, genomic instability and eventually senescence. [25] [26] [27] However, most of these studies have relied on culture protocols using normoxia (21% O 2 ). Culture of MSCs under hypoxic conditions, reproducing hypoxic niches, has been suggested as a way to maintain their immature phenotype 28 and to delay senescence. However, hypoxia has also been demonstrated to induce a form of replicative stress (o0.1% O 2 ) 29 and to hamper expression of homologous recombination factors (Rad51 and BRCA1) in cancer cell lines, BM-MSCs and in ADSCs. [30] [31] [32] In this work, we first intended to assess whether ADSCs were able to preserve their genomic integrity and decided to evaluate possible roles of the ING1 protein. First, we observed that following doxorubicin treatments in hypoxia (1% O 2 ), only ADSCs ('population doubling level'o20) could increase their ING1b protein levels, compared with U2OS cells. These results are consistent with previous studies emphasizing that the regulation of ING1b by DNA damage is not general, and may be cell type or stimulus specific. 14, 33, 34 We observed a decrease of HIF1α levels in ADSCs as a result of an ING1b accumulation upon doxorubicin treatment. Conversely, HIF1α levels increased in absence of ING1b. Additional experiments revealed that HIF1α destabilization by ING1b occurred at a protein level. This was also observed in U2OS cells cultured in hypoxia with lowered HIF1α protein levels in an ING1b-dependent manner. We show ING1b interacts with HIF1α and promotes its degradation. ING1b is known to prevent genomic stability through chromatin remodeling and cell cycle arrest [34] [35] [36] in response to DNA damage. ING1b as other ING proteins (ING2), is involved in the regulation of replicative fork progression, particularly in lesion bypass. 37, 38 Our data suggest that increasing ING1b levels, observed in ADSCs following doxorubicin treatment, could decrease the HIF1α protein levels, and consequently the hypoxic response. Thus, ING1b may prevent the hypoxiamediated genomic instability by opposing to the HIF1α-mediated transcriptional downregulation of proteins involved in DNA repair. 39, 40 Nonetheless, the hypoxic response may be regulated at different levels by different ING proteins. A previous study demonstrated that HIF activities could be modulated by ING4 12 (Figure 6e ). Indeed, under hypoxic conditions, stabilized HIF factors, which still interact with HPH-2, allow the recruitment of ING4 to the promoters of HIF target genes eventually preventing their expressions. Here, the plant homeodomain of ING4 seemed required for its interactions with HPH-2. Usually described to recognize H3K4me2 or H3K4me3, the PHD appears to bind other proteins, like HPH-2 or p65 in the case of ING4. 41 Therefore, an investigation on the ING1b PHD remains to be done for the comprehension of the regulation of HIF1α, and eventually its degradation. Besides, because this PHD is a common feature is not involved in a same manner during the adipocyte differentiation at 7 and 14 days of the adipogenic induction. FABP4, LPL and PPARγ2 mRNA levels were evaluated by Q-PCR. All mRNA levels were normalized to U6 expression. Bars represent mean ± S.E.M. Po0.05 (*), Po0.01 (**), Po0.001 (***), non significant (NS) in an unpaired Student's t-test (n = 44 Overall, we showed that SUMOylation of ING1b, critical for HIF1α degradation, might require proteins modulating SUMOylation, as PIAS4, or deSUMOylation processes.
The hypoxic response and HIF1α are critical for the maintenance of MSC properties and their immature state, 4, 45, 46 and the roles of ING proteins have been minimally studied in MSCs. Nonetheless, it seemed conceivable that ING1b, because of its functions could be involved in MSC fate. Adipogenesis has been frequently associated with mid to high oxygen tensions. Indeed, markers of adipocytes, like LPL or PPARγ2, have been shown to be reduced following HIF1α activation. 47, 48 As a consequence, we hypothesized that ING1b, by reducing HIF1α protein levels could facilitate this differentiation process. In agreement with our hypothesis, we observed that the presence of ING1b was required for expression of these adipocyte markers during the early/intermediate days of the adipogenesis process (day 7), whereas HIF1α was associated to their downregulations. Thus, we suggested that ING1b might be involved in the adipocyte differentiation, by decreasing the level of HIF1α in hypoxia. However, our results do not exclude the possibility that ING1b could have more roles in cell differentiation. Cheng et al. 49 showed that ING1, as a reader of H3K4me3 histone marks, was needed for myoblast differentiation by promoting the expression of myoblast-specific genes. H3K4me3 marks have been associated with active lineage-specific promoters in ADSCs (LPL, FABP4 and PPARγ2) during differentiation, and interestingly HIF1α has been reported to target open chromatin regions associated with H3K4me3. 50, 51 Thus, hypoxia may constitutively repress the expression of LPL, FABP4 and PPARγ2, through HIF1α. In addition, when ING1b and HIF1α were both depleted, adipocyte markers were normally expressed in hypoxic conditions, suggesting that adipocyte markers expression were no longer modulated. Thus, as for the genomic stability in hypoxia, ING1b might be involved in differentiation processes at different levels and may act differently according the presence of other transcription factors. We also evaluated the levels of DLK1/PREF-1, an early mesenchymal marker, 24 at the end of 7 days of adipogenic induction in hypoxia. Although our culture context was prone to keep elevated levels of DLH1/Pref-1 with probable elevated levels of HIF1α and HIF2α proteins, 52 we noticed that DLH1/Pref-1 decreased during this adipogenic induction. Taken together, we can conclude that the hypoxic culture context did not impede the triggering of the adipocyte differentiation. However, critical adipocyte markers like PPARγ2 present at more early stages or later adipocyte markers like LPL and mostly FABP4 have been modulated through the 14 days of adipogenic induction. Thus, we observed that ING1 was required for these adipocyte marker expressions under hypoxia until day 7 of adipogenic induction. Conversely, HIF1α, a main marker of the hypoxic response repressed their expressions.
Finally, we propose a mechanism where ING1b may prevent the hypoxic response, either by reducing HIF1α protein content in the nucleus or on chromatin. As we report, expressions of adipocyte markers (LPL, FABP4, PPARγ2) were reduced by HIF1α in hypoxia (Figures 5a, 6a and b) . Our study suggests that HIF1α degradation, promoted by ING1b, may increase expression levels of LPL, FABP4 and PPARγ2 (Figure 6b) . As a consequence, ING1b could potentiate the differentiation of ADSCs. Moreover, ING1b can interact with histone modifiers, like SIRT1, 53 already described to modulate HIF1α inactivation and to regulate differentiation of MSCs. 54, 55 Therefore, ING1b could take part in a complex regulating MSC's fate, especially under low oxygen tension.
In our study, we focused on adipocyte differentiation under hypoxic conditions. Of note, we failed to induce osteogenesis under hypoxia with ADSCs, although other studies have discussed the benefits of hypoxia on osteogenesis 23 (data not shown). Thus, we could not conclude on a role of ING1b in this context. Nevertheless, we proceeded to osteogenic induction in 21% O 2 (Supplementary Figure 7) and noticed that when ING1 was silenced in normoxic conditions, RUNX2, BGLAP and SP7 levels increased, as well as calcium deposits at 7 or 14 days, suggesting that as for adipocyte marker expressions under normoxia, ING1b might decrease osteoblast marker expressions in normoxia as well. Interestingly, even if it challenged the physiological sense, it appeared that HIF1α knockdown enhanced osteogenesis in normoxia. This suggests that HIF1α might be sufficiently maintained in normoxia for modulating expression of some targets. This is in accordance with the study by Palomäki et al. 6 that demonstrated great levels of HIF1α in normoxia in MSCs. Thus, ING1b appeared to display various roles according to the commitment and the culture context of ADSCs.
Conclusion
So far, ING proteins roles in hypoxia have been little studied. In this study we focused on ING1b in a mesenchymal stromal cell model, whose properties are particularly dependent on oxygen tension. As depicted in the Figure 6b , ING1b, under the control of its SUMOylation status appears to regulate the hypoxic response by triggering the proteasomal degradation of HIF1α, which eventually could lead to changes in its target genes expression (VEGF and EPO). Nonetheless, the hypoxic response may be regulated at different levels (Figure 6c ) by other ING proteins, as previous study demonstrated with ING4. 12 Materials and Methods Culture of ADSCs and induction of adipogenesis. Healthy donor recruitment followed the institutional review board approval and written informed consent process according to the Declaration of Helsinki. The stromal vascular fraction (SVF) was isolated from human abdominal lipoaspirates of adults undergoing reconstructive surgery after weight loss. 56 Lipoaspirates were centrifuged for 5 min at 600 × g. Phases containing adipocyte debris and red blood cells were removed. Tissues were digested with type IV collagenase (200 U/ml), neutral protease dispase (1.6 U/ml; Worthington, Freehold, NJ, USA) and DNAse (Pulmozyme,10 U/ml, Roche, Neuilly-sur-Seine, France) for 45 min at 37°C with gentle rocking. Lysates were passed through a 100 μm cell strainer and centrifuged for 10 min at 600 × g to obtain the SVF. Cells from the SVF were seeded at 1000 cells/cm 2 in αMEM supplemented with 10% selected fetal calf serum (HyClone, FCS, Thermo Scientific, Villebon sur Yvette, France), 1 ng/ml of bFGF (Cellgenix, Clermont Ferrand, France), penicillin (100 U/ml), and streptomycin (100 μg/ml; Life Technologies). ADSCs were analyzed for CD73, CD90, CD45 and CD31 presences at the end of the first passage (Supplementary Figure 1) . The established ADSC primary lines were passaged at 90% of confluence and plated at 2000-2500 cells/cm 2 and cultivated in αMEM supplemented with 10% selected Hyclone FCS, 1 ng/ml of bFGF, penicillin (100 U/ml), and streptomycin (100 μg/ml). ADSCs from three different donors were used in experiments between 15 and 20 cumulative population doublings.
Adipogenesis induction was performed using the hMSC Mesenchymal Stem Cell Adipogenic Differentiation Medium (Lonza, Verviers, Belgium) according to the manufacturer's recommendations. ADSCs were cultured at 37°C, 5% CO 2 and 21 or 1% O 2 , in agreement with the experiment purposes. The medium was changed every 3 days and the differentiation period lasted 7 or 14 days.
U2OS oesteosarcoma cells (p53 +/+ ) were grown in McCoy's 5A modified medium supplemented with 10% FCS (Life Technologies), penicillin (100 U/ml) and streptomycin (100 μg/ml).
Cells were amplified in normoxia (5% CO 2 , 21% O 2 ) at 37°C and placed in a Binder CB incubator (VWR International, Fontenay-sous-Bois, France) for a 24 h buffering time before each experiment under hypoxic conditions (5% CO 2 , 1% O 2 ) at 37°C.
Transfections. Silencing experiments were performed with Lipofectamine RNAiMAX Transfection Reagent (Life Technologies) according to the manufacturer's instructions. ING1b, PIAS4 stealth RNAi siRNAs (Life Technologies) and HIF1α siRNA (SC-35561, Santa Cruz Biotechnology, CliniSciences, Nanterre, France) were used in experiments. A Stealth RNAi siRNA Negative Control (Life Technologies) was used as control.
Stably transfected U2OS cells were previously produced using the empty pcDNA 3.1 vector, pcDNA 3.1 ING1b WT (coding for ING1b) and pcDNA 3.1 ING1b E195 and selected with G148 (0.5 mg/ml). 15 Transient transfections with empty pcDNA 3.1 (control), pcDNA 3.1 Flag ING1b WT plasmids were performed on ADSCs using a Human MSC Nucleofector Kit and the Nucleofector device (Lonza).
Western blot and immunoprecipitations experiments. Protein samples were obtained after washing cells in cold 1X PBS buffer and harvesting in RIPA buffer containing a protease inhibitor cocktail (Roche). Supernatants were collected after a 4°C centrifugation at 16 000 × g for 15 min. Samples were subjected to electrophoresis using the NuPage Novex Bis-Tris Gel Electrophoresis system (Life Technologies), and transferred to nitrocellulose membrane. The antibodies used were anti-PIAS4, anti-HIF1α, anti-ING1b (Cab3) (Santa Cruz Biotechnology), anti-βactin (Sigma, St Quentin Fallawier, France) and anti-gH2AX (Cell Signaling).
After 24 h of incubation under hypoxic conditions, cells were washed in cold 1X PBS buffer and harvested in IP lysis buffer (Thermo Fisher Scientific, Villebon sur Yvette, France), containing a protease inhibitor cocktail. Lysates were centrifuged at 4°C for 15 min at 16 000 × g and supernatants were recovered. Equal amounts of protein extracts were incubated with the ING1b (Cab1 and Cab5) or HIF1α antibodies for 3 h and then respectively bound to Dynabeads Protein G and protein A (Life Technologies) at 4°C with rocking. Beads were washed three times with cold 1X PBS buffer+0.01% Tween20. Immunoprecipitated samples were analyzed by Western blot.
Western blots pictures were obtained with a Gbox imager (Syngene, Cambridge, UK) and were quantified using ImageJ software (U. S. National Institutes of Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/). Results display the amount of protein of interest normalized on actin amount. Data are represented as percentages.
Quantitative RT-PCR. RNA was extracted using the RNeasy Kit (Qiagen, Courtaboeuf, France) and cDNAs were generated using the Superscript II reverse transcriptase (Life Technologies). RT-PCR amplification experiments were performed with the SYBR Green PCR Master Mix on a StepOnePlus Real-Time PCR System (Applied Biosystems, Life Technologies, Villebon sur Yvette, France). The relative gene expression was calculated with the 2 −ΔΔCT method. All the results were normalized to U6 expression (similar results were obtained for housekeeping genes such as RPL13a, not shown). The primer sequences used in RT-PCR are listed in Supplementary Figure 8 .
Statistical analyzes. ADSC PCR data is presented as mean ± S.E.M. The statistical significance was determined using an unpaired Student's t-test. Values of Po0.05 (*), Po0.01 (**) and Po0.001 (***) were considered statistically significant. Experiments were repeated three times.
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